$IPSC SEC Filings

Filed On	Filing
02 Oct 2026	8-K: Regulation FD Disclosure; Other Events CNTY - 813: Scalable Production of Allo - Evasion TM 5.0 - Engineered iPSC Islets for Off - the - Shelf Cell Therapies G. Grant Welstead, PhD SVP, Head of Research
15 Sep 2026	Form 4: Pfeiffenberger Brent, Director Gave up 13,850 shares to cover exercise price or tax ($26.9K)
15 Sep 2026	Form 4: Russotti Gregory, See Remarks Sold 2,587 shares ($4.99K)
15 Sep 2026	Form 4: Carr Douglas, SVP Finance & Operations Sold 1,658 shares ($3.2K)
14 Sep 2026	144
14 Sep 2026	144
10 Sep 2026	Form 4: Truitt Joseph, Director Granted 148,000 Stock Option (right to buy)
10 Sep 2026	Form 3: Truitt Joseph, Director No securities owned
09 Sep 2026	Form 4: Pfeiffenberger Brent, Director Gave up 463 shares to cover exercise price or tax ($977)
09 Sep 2026	Form 4: Russotti Gregory, See Remarks Sold 534 shares ($1.09K)
09 Sep 2026	Form 4: Carr Douglas, SVP Finance & Operations Sold 254 shares ($521)
09 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure PHILADELPHIA, September 9, 2026 - Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases, including type 1 diabetes (T1...
08 Sep 2026	144
18 Aug 2026	Form 4: Pfeiffenberger Brent, Director Gave up 31,172 shares to cover exercise price or tax ($59.9K)
12 Aug 2026	10-Q
12 Aug 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
05 Aug 2026	Form 4: Carr Douglas, SVP Finance & Operations Sold 275 shares ($544)
16 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation
15 Jun 2026	Form 4: Russotti Gregory, See Remarks Sold 2,584 shares ($5.77K)
15 Jun 2026	Form 4: Carr Douglas, SVP Finance & Operations Sold 1,654 shares ($3.69K)

Comments